These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 87051)

  • 1. Electrophoretic evaluation of different hormonal receptor sites in the prostate during anti-hormonal treatment and in response to hormones.
    Fischer DR; Gevers W
    Urol Int; 1979; 34(2):95-104. PubMed ID: 87051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Possibilities for the evaluation of receptor sites in benign prostatic hyperplasia and carcinoma of the prostate (author's transl)].
    Fischer D; Gevers W; Bressel M
    Urologe A; 1980 Nov; 19(6):326-30. PubMed ID: 6162265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hormonal receptors and other procedures for predicting clinical response in cancer of the prostate].
    Habib FK; Chisholm GD
    Arch Esp Urol; 1984 Dec; 37 Suppl 2():751-9. PubMed ID: 6085672
    [No Abstract]   [Full Text] [Related]  

  • 4. [Predictive value of the determination of receptors in carcinoma of the prostate].
    Castellanos JM; Galán A; Calvo MA; Schwartz S
    Rev Esp Oncol; 1984; 31(2):265-77. PubMed ID: 6085864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Studies on sex hormone-binding globulin in the prostate].
    Jiang H; Chen Z
    Zhonghua Nan Ke Xue; 2004 Jun; 10(6):443-4, 448. PubMed ID: 15267211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of estrogen and SHBG in prostate physiology.
    Farnsworth WE
    Prostate; 1996 Jan; 28(1):17-23. PubMed ID: 8545277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Demonstration of a progestin receptor in human benign prostatic hyperplasia and prostatic carcinoma.
    Gustafsson JA; Ekman P; Pousette A; Snochowski M; Högberg B
    Invest Urol; 1978 Mar; 15(5):361-6. PubMed ID: 76618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peripheral hormone levels in controls and patients with prostatic cancer or benign prostatic hyperplasia: results from the Dutch-Japanese case-control study.
    de Jong FH; Oishi K; Hayes RB; Bogdanowicz JF; Raatgever JW; van der Maas PJ; Yoshida O; Schroeder FH
    Cancer Res; 1991 Jul; 51(13):3445-50. PubMed ID: 1711411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen receptor isoforms in human and rat prostate.
    Xia SJ; Hao GY; Tang XD
    Asian J Androl; 2000 Dec; 2(4):307-10. PubMed ID: 11202423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Hormone-dependency of the human prostate].
    Robel P
    Bull Cancer; 1986; 73(1):19-22. PubMed ID: 2430651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide hormones, serotonin, and other cell differentiation markers in benign hyperplasia and in carcinoma of the prostate.
    Abrahamsson PA; Alumets J; Wadström LB; Falkmer S; Grimelius L
    Prog Clin Biol Res; 1987; 243A():489-502. PubMed ID: 2443920
    [No Abstract]   [Full Text] [Related]  

  • 12. Sex steroid hormones and the androgen receptor gene CAG repeat and subsequent risk of prostate cancer in the prostate-specific antigen era.
    Platz EA; Leitzmann MF; Rifai N; Kantoff PW; Chen YC; Stampfer MJ; Willett WC; Giovannucci E
    Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1262-9. PubMed ID: 15894683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A preliminary report on the measurement of cytosolic and nuclear prostatic tissue steroid receptors.
    Olsson CA; deVere White R; Goldstein I; Traish AM; Müller RE; Wotiz HH
    Prog Clin Biol Res; 1979; 33():209-21. PubMed ID: 93750
    [No Abstract]   [Full Text] [Related]  

  • 14. The epidemiology and function of sex hormone-binding globulin.
    Moore JW; Bulbrook RD
    Oxf Rev Reprod Biol; 1988; 10():180-236. PubMed ID: 2469051
    [No Abstract]   [Full Text] [Related]  

  • 15. [Comparison of natural and synthetic ligands for determining androgen receptors in prostatic tumors and prostatic nodular hyperplasia].
    Kushlinskiĭ NR; Bassalyk LS; Degtiar' VG
    Med Radiol (Mosk); 1983 Aug; 28(8):13-6. PubMed ID: 6193390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Steroid levels in cancer of the prostate--markers of tumor differentiation and adequacy of anti-androgen therapy.
    Geller J; Albert J; Nachtsheim D; Loza D; Lippman S
    Prog Clin Biol Res; 1979; 33():103-11. PubMed ID: 93747
    [No Abstract]   [Full Text] [Related]  

  • 17. Sex hormone-binding globulin mediates prostate androgen receptor action via a novel signaling pathway.
    Ding VD; Moller DE; Feeney WP; Didolkar V; Nakhla AM; Rhodes L; Rosner W; Smith RG
    Endocrinology; 1998 Jan; 139(1):213-8. PubMed ID: 9421417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex hormone binding globulin and aging.
    Caldwell JD; Jirikowski GF
    Horm Metab Res; 2009 Mar; 41(3):173-82. PubMed ID: 18956301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Control of prostate growth.
    Coffey DS; Isaacs JT
    Urology; 1981 Mar; 17(Suppl 3):17-24. PubMed ID: 6163242
    [No Abstract]   [Full Text] [Related]  

  • 20. Estrogen receptors in human prostate: evidence for multiple binding sites.
    Ekman P; Barrack ER; Greene GL; Jensen EV; Walsh PC
    J Clin Endocrinol Metab; 1983 Jul; 57(1):166-76. PubMed ID: 6189851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.